Zai Lab Limited (ZLAB) CEO Samantha Du on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/10/21
Zai Lab Announces Second Quarter 2021 Financial Results and Corporate UpdatesGlobeNewsWire • 08/09/21
Zai Lab: Best Now Capital Gain Biotech For Near-Term Wealth-Building, So Say Market-MakersSeeking Alpha • 07/18/21
Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in OncologyGlobeNewsWire • 06/16/21
Week In Review: Zai Lab Enters $338 Million Agreement To In-License KRAS InhibitorSeeking Alpha • 06/07/21
Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater ChinaPRNewsWire • 06/01/21
Zai Lab Announces First Patient Treated in China in the Registrational Phase 2 TRIDENT-1 Study of RepotrectinibGlobeNewsWire • 05/28/21
Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung CancerGlobeNewsWire • 05/24/21
Zai Lab Limited (ZLAB) CEO Samantha Du on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel DrugsSeeking Alpha • 04/26/21
Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe OptionGlobeNewsWire • 04/23/21
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary SharesGlobeNewsWire • 04/20/21